CA1220746A - Luzopeptine e.sub.2 - Google Patents

Luzopeptine e.sub.2

Info

Publication number
CA1220746A
CA1220746A CA000446122A CA446122A CA1220746A CA 1220746 A CA1220746 A CA 1220746A CA 000446122 A CA000446122 A CA 000446122A CA 446122 A CA446122 A CA 446122A CA 1220746 A CA1220746 A CA 1220746A
Authority
CA
Canada
Prior art keywords
luzopeptin
methionine
cysteine
antibiotic
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000446122A
Other languages
English (en)
Inventor
Terrence W. Doyle
Charles A. Claridge
Henry Schmitz
Marianne F. Kammer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Application granted granted Critical
Publication of CA1220746A publication Critical patent/CA1220746A/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000446122A 1983-01-31 1984-01-26 Luzopeptine e.sub.2 Expired CA1220746A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46257783A 1983-01-31 1983-01-31
US462,577 1983-01-31

Publications (1)

Publication Number Publication Date
CA1220746A true CA1220746A (fr) 1987-04-21

Family

ID=23836950

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000446122A Expired CA1220746A (fr) 1983-01-31 1984-01-26 Luzopeptine e.sub.2

Country Status (15)

Country Link
JP (1) JPH0645638B2 (fr)
KR (1) KR880001638B1 (fr)
AU (1) AU566569B2 (fr)
BE (1) BE898807A (fr)
CA (1) CA1220746A (fr)
CH (1) CH663415A5 (fr)
DE (1) DE3403125A1 (fr)
FR (1) FR2540116B1 (fr)
GB (1) GB2134119B (fr)
GR (1) GR81749B (fr)
IT (1) IT1175927B (fr)
MY (1) MY8800015A (fr)
NL (1) NL8400237A (fr)
SE (1) SE464582B (fr)
ZA (1) ZA84613B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643871A (en) * 1993-11-23 1997-07-01 Bristol-Meyers Squibb Company Antitumor antibiotics
GB2294265A (en) * 1994-10-20 1996-04-24 Merck & Co Inc Cyclic depsipeptides obtained from Actinomycete sp.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2050384B (en) * 1979-04-02 1983-04-07 Bristol Myers Co Antitumor antibacterial agents

Also Published As

Publication number Publication date
GR81749B (fr) 1984-12-12
GB2134119B (en) 1986-04-30
ZA84613B (en) 1984-09-26
IT8419348A0 (it) 1984-01-27
JPS59173091A (ja) 1984-09-29
KR880001638B1 (ko) 1988-09-03
IT1175927B (it) 1987-08-12
CH663415A5 (de) 1987-12-15
DE3403125A1 (de) 1984-10-31
MY8800015A (en) 1988-12-31
AU2372184A (en) 1984-08-02
KR840007106A (ko) 1984-12-05
AU566569B2 (en) 1987-10-22
BE898807A (fr) 1984-07-31
SE8400450L (sv) 1984-08-01
SE8400450D0 (sv) 1984-01-30
GB8402410D0 (en) 1984-02-29
SE464582B (sv) 1991-05-13
JPH0645638B2 (ja) 1994-06-15
NL8400237A (nl) 1984-08-16
FR2540116A1 (fr) 1984-08-03
GB2134119A (en) 1984-08-08
FR2540116B1 (fr) 1989-08-18

Similar Documents

Publication Publication Date Title
EP0182315B1 (fr) Antibiotique NK84-0218, compositions pharmaceutiques le contenant et procédé pour sa production
HU193973B (en) Process for preparing 4'-dechloro-rebeccamicin
JPS5910798B2 (ja) 新しいリフアマイシン類の製造方法
JP2766421B2 (ja) 新規化合物チオマリノール
CA1220746A (fr) Luzopeptine e.sub.2
US4373028A (en) Culture of Nocardia ATCC 31309
US4081531A (en) Antibiotic mimosamycin
US4764602A (en) Antibiotics, and their production
AU752169B2 (en) Macrolides with antitumor activity
US5849540A (en) Thiodepsipeptide isolated from a marine actinomycete
US4292309A (en) Antibiotics C-14482 B1, B2 and B3
US4282322A (en) Process for enzymatic deacylation of antibiotics
US5281417A (en) Antitumor process employing novel fermentate of an Actinomadura strain
US4440752A (en) Antibiotics Y-16482 α and/or Y-16482 β, a process for production thereof, and a pharmaceutical composition containing either or both of them
EP0253413B1 (fr) Antibiotiques appelés "Mureidomycines A,B,C et D", leur procédé de préparation et leur emploi thérapeutique
US4194064A (en) Production of nanaomycin B
US4667027A (en) Cephem compounds and their production
CA1206902A (fr) Antibiotique 273a.sub.1
CA1104078A (fr) Traduction non-disponible
Higashide et al. Antibiotic C-14482 A 1 and method for producing same
Higashide et al. Antibiotics C-14482 B 1, B 2 and B 3
Cassidy et al. Antibiotics 890A 1 and 890A 3
JPH08208644A (ja) 新規抗生物質クレミマイシンとその製造法及び用途
GB1575780A (en) Antibiotics and a process for their production
JPH0799982A (ja) 新規抗生物質MJ885−mF8およびその製造方法

Legal Events

Date Code Title Description
MKEX Expiry